Showing 41 - 60 results of 270 for search '"ovarian cancer"', query time: 0.06s Refine Results
  1. 41
  2. 42

    Repurposing Drugs in Controlling Recurrent Platinum-Resistant Clear-Cell Ovarian Cancer by Woraporn Sinsuwan, Phawit Norchai

    Published 2023-01-01
    “…Recurrent platinum-resistant clear-cell ovarian cancer has a low overall survival duration of 7-8 months, making it a fatal disease. …”
    Get full text
    Article
  3. 43

    DOCK4 Is a Platinum-Chemosensitive and Prognostic-Related Biomarker in Ovarian Cancer by Qianqian Zhao, Jie Zhong, Ping Lu, Xiao Feng, Ying Han, Chenqi Ling, Wenke Guo, Weijin Zhou, Fudong Yu

    Published 2021-01-01
    “…In conclusion, DOCK4 is potentially associated with immune cell infiltration and represents a valuable prognostic biomarker in ovarian cancer patients.…”
    Get full text
    Article
  4. 44

    Exosomal miR-543 Inhibits the Proliferation of Ovarian Cancer by Targeting IGF2 by Shupei Zhang, Diling Pan, Shaoyu Zhang, Qiumei Wu, Lan Zhen, Shihuang Liu, Jingjing Chen, Rong Lin, Qiuhua Hong, Xiangqin Zheng, Huan Yi

    Published 2022-01-01
    “…Objective. Ovarian cancer (OvCa) is the most lethal gynaecological malignancy worldwide. …”
    Get full text
    Article
  5. 45
  6. 46
  7. 47

    The compositional behavior of the human T cell receptor repertoire in ovarian cancer compared to healthy donors by Miriam Zuckerbrot-Schuldenfrei, Alona Zilberberg, Sol Efroni

    Published 2025-01-01
    “…In this study, we sampled the repertoire of 85 women: ovarian cancer patients (OC) and healthy donors (HD), generating a dataset of T cell clones and their abundance. …”
    Get full text
    Article
  8. 48
  9. 49

    Intraepithelial corneal deposits associated with Mirvetuximab soravtansine use for platinum-resistant ovarian cancer by Charlotte McRae, Rachael Cowan, Macy Green, Jack S. Parker

    Published 2025-06-01
    “…Observations: A 63-year-old female with metastatic ovarian cancer diagnosed with intraepithelial corneal deposits two weeks after her first MIRV infusion. …”
    Get full text
    Article
  10. 50
  11. 51
  12. 52

    Increased Expression of the Pro-Protein Convertase Furin Predicts Decreased Survival in Ovarian Cancer by Robert E. Page, Andrés J. P. Klein-Szanto, Samuel Litwin, Emmanuelle Nicolas, Raid Al-Jumaily, Peter Alexander, Andrew K. Godwin, Eric A. Ross, Russell J. Schilder, Daniel E. Bassi

    Published 2007-01-01
    “…Conclusions: Our studies point to a clear relationship between furin and ovarian cancer. In addition, these results show that furin exhibits the closest association with ovarian cancer among the ubiquitously expressed PCs, arguing against the redundancy of these proteases. …”
    Get full text
    Article
  13. 53
  14. 54
  15. 55

    Histopathology and proteomics are synergistic for high-grade serous ovarian cancer platinum response prediction by Oz Kilim, Alex Olar, András Biricz, Lilla Madaras, Péter Pollner, Zoltán Szállási, Zsofia Sztupinszki, István Csabai

    Published 2025-01-01
    “…Abstract Patients with High-Grade Serous Ovarian Cancer (HGSOC) exhibit varied responses to treatment, with 20–30% showing de novo resistance to platinum-based chemotherapy. …”
    Get full text
    Article
  16. 56

    LED Light-Activated Hypocrellin B Induces Mitochondrial Damage of Ovarian Cancer Cells by Yuan Jiang, Albert Wingnang Leung, Junyan Xiang, Chuanshan Xu

    Published 2012-01-01
    “…In the present study, our aim is to investigate the effect of LED light-activated hypocrellin B on mitochondria of ovarian cancer cells. Material and Methods. Ovarian cancer HO-8910 cells were incubated with hypocrellin B at the concentration of 2.5 μM for 5 h and then irradiated by blue light from a novel LED source. …”
    Get full text
    Article
  17. 57
  18. 58

    Unlocking prognostic potential: A genomic signature of caloric restriction in patients with epithelial ovarian cancer. by Ori Tal, Tamar Zahavi, Liat Anabel Sinberger, Mali Salmon-Divon

    Published 2025-01-01
    “…In this study, we calculated a transcriptomic signature based on caloric-restriction for ovarian cancer patients and explored its correlation with ovarian cancer progression.…”
    Get full text
    Article
  19. 59

    Early Recurrence of Ovarian Cancer during Pregnancy after Primary Staging Surgery in the First Trimester by Munetoshi Akazawa, Kazunori Hashimoto

    Published 2020-01-01
    “…We present the case of recurrence of ovarian cancer during pregnancy regardless of primary staging surgery performed in the first trimester of the same pregnancy. …”
    Get full text
    Article
  20. 60